Ergoteles’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-68,764
| Closed | -$1.44M | – | 724 |
|
2023
Q2 | $1.44M | Buy |
+68,764
| New | +$1.44M | 0.07% | 354 |
|
2022
Q1 | – | Sell |
-34,997
| Closed | -$766K | – | 1607 |
|
2021
Q4 | $766K | Sell |
34,997
-12,071
| -26% | -$264K | 0.03% | 495 |
|
2021
Q3 | $899K | Buy |
+47,068
| New | +$899K | 0.03% | 407 |
|